Genmab Announces Positive Topline Results in Phase III ANDROMEDA Study of Daratumumab in Light-chain (AL) Amyloidosis – Financialbuzz.com

Company Announcement Copenhagen, Denmark; May 28, 2020 Genmab A/S (Nasdaq: GMAB) announced today positive topline results from the Phase III ANDROMEDA (AMY3001) study of subcutaneous (SC) daratumumab in combination with cyclophosphamide, bortezomib and dexamethasone (CyBorD) for patients with newly diagnosed light-chain (AL) amyloidosis. The study, conducted by Janssen Biotech, Inc. (Janssen), met the primary endpoint of percentage of patients with hematologic complete response.

Read more
Opdivo + Yervoy receive FDA approval combined with limited chemotherapy as first-line treatment of metastatic or recurrent NSCLC – The Cancer Letter

publication date: May. 29, 2020 FDA has approved Opdivo and Yervoy (nivolumab + ipilimumab) in combination with two cycles of platinum-doublet chemotherapy as first-line treatment for patients with metastatic or recurrent non-small cell lung cancer, with no epidermal growth factor receptor or anaplastic lymphoma kinase genomic tumor aberrations.

Read more
Research at MDI Biological Laboratory explores novel pathways of regeneration and tumorigenesis – Bangor Daily News

BAR HARBOR Research by scientists at the MDI Biological Laboratoryis opening up new approaches to promoting tissue regeneration in organs damaged by disease or injury. In recent years, research in regenerative biology has focused on stem cell therapies that reprogram the bodys own cells to replace damaged tissue, which is a complicated process because it involves turning genes in the cells nucleus on and off

Read more
Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury – BMC Blogs Network

Acute lung injury (ALI) is a devastating disease process involving pulmonary edema and atelectasis caused by capillary membrane injury [1]. The main clinical manifestation is the acute onset of hypoxic respiratory failure, which can subsequently trigger a cascade of serious complications and even death [2]

Read more
Stem Cell Source Market Size Analysis and Growth (2020-2025) – 3rd Watch News

Stem Cell Source Market Latest Research Report 2020: The Stem Cell Source report provides an independent information about the Stem Cell Source industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porters five force analysis, and key companies Download Premium Sample Copy Of This Report: Download FREE Sample PDF! In this report, our team offers a thorough investigation of Stem Cell Source Market, SWOT examination of the most prominent players right now.

Read more
Stem Cell Cartilage Regeneration Market: Analysis of Prevailing Trends In The Parent Market 2026 – Cole of Duty

Stem Cell Cartilage Regeneration Marketreport studies the Stem Cell Cartilage Regeneration with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Stem Cell Cartilage RegenerationMarket analysis segmented by companies, region, type and applications in the report

Read more